Call 0114 230 8401 for more information

Visit mscrnd.com

Which are the main Funding Schemes relevant to me?

There are several funding schemes (‘Types of Action’) under the Horizon 2020 banner, making it difficult for an SMEsClick for description to easily identify which are appropriate for their company.

The funding opportunities of particular relevance to SMEs come within the Leadership in Enabling & Industrial Technologies (LEIT), Societal Challenges and SME Instrument schemes.

Collaborative funding within Leadership in Enabling &
Industrial Technologies (LEIT) and Societal Challenges

  • Funding opportunities are set out in multi-year work programmes with pre-determined thematic calls.
  • Projects require an SME to be part of a consortium, with a minimum of 3 partners from different countries
  • LEIT addresses TRLsClick for description from 3-4 up to 7, with an overall centre of gravity in the range from 5-6. (Elsewhere, in Cross-cutting Activities (Focus Areas), TRLs are often in the ranges 4-6 or 5-7).

There are two main types of project, with different funding rates:

Research & Innovation Action (RIA)

  • Projects to establish new knowledge and/or explore the feasibility of a new or improved technology, product, process, service or solution. (Not dissimilar to the old UK’s Proof of Concept scheme).
  • The funding rate is 100%.
  • The value of project funding can vary by call, but appropriate budgets are typically between €3.5m and €5.5m.* (Maximum EC contributions for ongoing and completed projects have ranged between €0.27m and €27.8m (average €4.9m)).**
  • Typical TRLs 3-6.*
  • Project lengths range from 12 months to 6 years (average 41 months).**
  • The number of partners is typically between 4 and 18 (average 12).**

 

*Source: Horizon 2020 Work Programme 2016 – 2017 (European Commission Decision C(2016)4614 of 25 July 2016), available at European Commission Research & Innovation Participant Portal – Reference Documents: http://ec.europa.eu/research/participants/portal/desktop/en/funding/reference_docs.html#h2020-work-programmes-2016-17.

**Source: CORDIS – EU research projects under Horizon 2020 (2014-2020), available at: https://data.europa.eu/euodp/en/data/dataset/cordisH2020projects. Accessed 2017-01-04.

Innovation Action (IA)

  • Projects directly aimed at producing plans or designs for new or improved products, processes or services.
  • The funding rate is 70%.
  • The value of project funding can vary by call, but appropriate budgets are typically between €5.5m and €8.0* (Maximum EC contributions for ongoing and completed projects have ranged between €0.49m and €39.3m (average €5.2m)).**
  • Typical TRLs 5-7.*
  • Project lengths range from 14 months to 5.4 years (average 35 months).**
  • The number of partners is typically between 4 and 16 (average 12).**

 

*Source: Horizon 2020 Work Programme 2016 – 2017 (European Commission Decision C(2016)4614 of 25 July 2016), available at European Commission Research & Innovation Participant Portal – Reference Documents: http://ec.europa.eu/research/participants/portal/desktop/en/funding/reference_docs.html#h2020-work-programmes-2016-17

**Source: CORDIS – EU research projects under Horizon 2020 (2014-2020), available at: https://data.europa.eu/euodp/en/data/dataset/cordisH2020projects. Accessed 2017-01-04.

SME Instrument

SME Instrument projects are for single SMEs, although it is possible to collaborate. Funding is available for two phases of a project:

SME Instrument Phase 1 (SME-1) projects

  • Concept and production of a technical and € commercial feasibility assessment, including a business plan, for a breakthrough innovation.
  • Lump sum funding is provided of €50,000 (max 70% of project cost).
  • Typical TRL 6.*
  • Project length is about 6 months (average 5 months).**

 

*Source: Horizon 2020 Work Programme 2016 – 2017 (European Commission Decision C(2016)4614 of 25 July 2016), available at European Commission Research & Innovation Participant Portal – Reference Documents: http://ec.europa.eu/research/participants/portal/desktop/en/funding/reference_docs.html#h2020-work-programmes-2016-17.

**Source: CORDIS – EU research projects under Horizon 2020 (2014-2020), available at: https://data.europa.eu/euodp/en/data/dataset/cordisH2020projects. Accessed 2017-01-04

SME Instrument Phase 2 (SME-2) projects

  • Projects aimed at bringing innovation projects to investment readiness and maturity for market take-up, underpinned by a strong business plan.
  • The funding rate is 70%.
  • The value of project funding typically ranges between €500k to €2.5m. (Maximum EC contributions for ongoing and completed projects have averaged €1.6m).**
  • Typical TRLs 6 and above.*
  • Projects should last between 12 and 24 months (up to 36 months in SMEInst-05-2016-2017 (healthcare biotechnology)*) (average is 24 months).**

 

*Source: Horizon 2020 Work Programme 2016 – 2017 (European Commission Decision C(2016)4614 of 25 July 2016), available at European Commission Research & Innovation Participant Portal – Reference Documents here.

**Source: CORDIS – EU research projects under Horizon 2020 (2014-2020), available https://data.europa.eu/euodp/en/data/dataset/cordisH2020projects. Accessed 2017-01-04

Phase 3 support

In Phase 3, the SME Instrument does not provide grants but rather support to SME Instrument Phase 1 and Phase 2 beneficiaries. It does this by offering access to a range of additional services such as investment-readiness support, potential access to risk finance, and Enterprise Europe Network (EEN) services, in order to help successful go-to-market of the innovation.

The funding schemes (Types of Action) discussed above, i.e., those of most relevance to SMEs within the Work Programme 2016-2017 of Horizon 2020, have indicative budgets for 2017 allocated as follows:

Type of Action Indicative Budget 2017 (EUR million)
SME Instrument* 437.51
Research and Innovation Action (RIA) 2,054.30
Innovation Action (IA) 1,149.36
pool of RIA and IA projects** 463.31
pool of RIA, IA and CSA*** projects** 136.99

Source: Horizon 2020 Work Programme 2016 – 2017. (European Commission Decision C(2016)4614 of 25 July 2016), available at European Commission Research & Innovation Participant Portal – Reference Documents here.

* of which ≤10% will be used for phase 1 funding, ≥87% for phase 2 funding and ≥1% for phase 3 related actions

** budgets shared between topics with different Types of Action, for allocation at evaluation decision

*** Coordination and Support Action (CSA)

error: Content is protected !!